"ColumbiaDoctors provides patients with the expertise of more than 1,800 highly regarded physicians, surgeons, dentists, and nurses, coupled with the prestige of Columbia University, one of the nation’s oldest and finest universities."

During the past decade, Columbia University Medical Center - Herbert Irving Pavilion conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 5 clinical trials were completed, i.e. on average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 5 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Columbia University Medical Center - Herbert Irving Pavilion" #1 sponsor was "Pfizer" with 4 trials, followed by "Gilead Sciences" with 2 trials sponsored, "IDEAYA Biosciences" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "ADC Therapeutics S.A." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia University Medical Center - Herbert Irving Pavilion" #1 collaborator was "ICON plc" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Columbia University Medical Center - Herbert Irving Pavilion" are "Cutaneous Melanoma" (2 trials), "Renal Cell Carcinoma" (2 trials), "Squamous Cell Carcinoma of the Head and Neck" (2 trials), "Urothelial Carcinoma" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Columbia University Medical Center - Herbert Irving Pavilion" in a lesser frequency.

Most popular intervention types in "Columbia University Medical Center - Herbert Irving Pavilion" are "Drug" (17 trials), "Biological" (7 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine" (2 trials), "Docetaxel" (2 trials), "Gemcitabine" (2 trials), "Magrolimab" (2 trials) and "Nivolumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Columbia University Medical Center - Herbert Irving Pavilion" are 16 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Columbia University Medical Center - Herbert Irving Pavilion". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Columbia University Medical Center - Herbert Irving Pavilion, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Columbia University Medical Center - Herbert Irving Pavilion, 11 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".